While we wait some interesting reading in the Dana
Post# of 72440
(Total Views: 532)
Posted On: 11/05/2018 3:26:58 PM
While we wait some interesting reading in the DanaFarber newsletter:
DFCI Newsletter (newsletter@dfci.harvard.edu)
To:you Details
Dana-Farber Cancer Institute logo The Jimmy Fund logo
Spotlight logo
NOVEMBER 5, 2018
PMC check presentation
Pan-Mass Challenge announces unprecedented $56 million gift to Dana-Farber
The Pan-Mass Challenge announced the largest gift ever contributed by an organization to Dana-Farber Cancer Institute – a record-breaking $56 million raised in 2018 that will support adult and pediatric patient care and cancer research. The organization exceeded last year's contribution by a staggering $5 million and, since its inception in 1980, has raised a total of $654 million.
>> READ MORE
Jacob Sands, MD
Can immunotherapy help patients with small cell lung cancer?
Small cell lung cancer is the most aggressive type of lung cancer. Treatment with immunotherapy drugs hasn't yet been approved for small cell lung cancer, but some early findings in clinical trials suggest this type of treatment may have potential.
>> READ MORE
glasses of wine
What you should know about alcohol consumption and personal health
The link between alcohol consumption and personal health has long been a controversial subject. For several decades, research has found conflicting evidence regarding alcohol's physical effects. Our expert discusses the risks and benefits.
>> READ MORE
ALSO IN THIS ISSUE
Ursula Matulonis, MD
Standard therapy for newly diagnosed ovarian cancer enters new era
After seeing few updates for more than two decades, treatment options for ovarian cancer are beginning to expand rapidly. As doctors and scientists have learned more about the molecular forces at work in ovarian cancer, and about the immune system’s role in fighting the disease, several new therapies are being used, either as FDA-approved drugs or as the focus of clinical trials.
>> READ MORE
Ann LaCasce, MD (left) and Sandra Linberg
From recurrence to remission: Lymphoma patient is cancer-free after CAR T-cell therapy
In early 2018, Sandra Linberg received an infusion of CAR T cells only a few months after the therapy was approved for treating her type of cancer. After only a month, her lymphoma had completely disappeared – she was in a complete remission. "Those little warrior cells took care of it," declared Linberg, who has continued to be cancer-free.
>> READ MORE
David A. Reardon, MD
<< MAKE AN APPOINTMENT >>
We are committed to providing the most advanced and compassionate care possible. First appointments are often available within 24 hours. Connect online or call 866-705-0122 (adult patients) or 877-689-0699 (pediatric patients).
>> CONTACT US
MORE STORIES
What is a biomarker? >>
What are the symptoms of stomach cancer? >>
Daughter draws strength from late father in brain cancer battle >>
Dana-Farber Care Card
Dana-Farber Care Card
The Dana-Farber Care Card is a reloadable spending card for patients, family members, friends, staff, and other visitors to make cashless purchases for food and services.
Buy a Care Card
SAVE THE DATE
Bruce MacDonald, LICSW
Young Adult Support Group
Wednesday, November 7, 2018
5:30 – 7:00 p.m.
450 Brookline Ave., Boston, MA
Patients in their 20's and 30's who are in treatment or recently out of treatment are eligible to join this support group. Call 617-632-5657 or email Bruce MacDonald, LICSW, to register.
View events calendar
Dana-Farber Marathon Challenge runner
Dana-Farber Marathon Challenge
Monday, April 15, 2019
Boston, MA
Apply now to join Dana-Farber’s team in the 2019 Boston Marathon®, and run toward the ultimate finish line: a world without cancer.
Apply today
HOW TO HELP
Boston Red Sox World Series Championship ornament
Celebrate the Red Sox win with a limited edition ornament
Surprise your loved ones with a limited edition Red Sox World Champions holiday ornament and other Red Sox-themed items this holiday season.
Place your order today
Gene Display tiles
Make your mark on cancer
Support cancer research through the Gene Display. Deadline for February installation is December 31.
Name a gene
SUBSCRIBE >>
US News and World Report Best Hospital badges
Feedback - Thoughts
about our newsletter?
Email us
DFCI Newsletter (newsletter@dfci.harvard.edu)
To:you Details
Dana-Farber Cancer Institute logo The Jimmy Fund logo
Spotlight logo
NOVEMBER 5, 2018
PMC check presentation
Pan-Mass Challenge announces unprecedented $56 million gift to Dana-Farber
The Pan-Mass Challenge announced the largest gift ever contributed by an organization to Dana-Farber Cancer Institute – a record-breaking $56 million raised in 2018 that will support adult and pediatric patient care and cancer research. The organization exceeded last year's contribution by a staggering $5 million and, since its inception in 1980, has raised a total of $654 million.
>> READ MORE
Jacob Sands, MD
Can immunotherapy help patients with small cell lung cancer?
Small cell lung cancer is the most aggressive type of lung cancer. Treatment with immunotherapy drugs hasn't yet been approved for small cell lung cancer, but some early findings in clinical trials suggest this type of treatment may have potential.
>> READ MORE
glasses of wine
What you should know about alcohol consumption and personal health
The link between alcohol consumption and personal health has long been a controversial subject. For several decades, research has found conflicting evidence regarding alcohol's physical effects. Our expert discusses the risks and benefits.
>> READ MORE
ALSO IN THIS ISSUE
Ursula Matulonis, MD
Standard therapy for newly diagnosed ovarian cancer enters new era
After seeing few updates for more than two decades, treatment options for ovarian cancer are beginning to expand rapidly. As doctors and scientists have learned more about the molecular forces at work in ovarian cancer, and about the immune system’s role in fighting the disease, several new therapies are being used, either as FDA-approved drugs or as the focus of clinical trials.
>> READ MORE
Ann LaCasce, MD (left) and Sandra Linberg
From recurrence to remission: Lymphoma patient is cancer-free after CAR T-cell therapy
In early 2018, Sandra Linberg received an infusion of CAR T cells only a few months after the therapy was approved for treating her type of cancer. After only a month, her lymphoma had completely disappeared – she was in a complete remission. "Those little warrior cells took care of it," declared Linberg, who has continued to be cancer-free.
>> READ MORE
David A. Reardon, MD
<< MAKE AN APPOINTMENT >>
We are committed to providing the most advanced and compassionate care possible. First appointments are often available within 24 hours. Connect online or call 866-705-0122 (adult patients) or 877-689-0699 (pediatric patients).
>> CONTACT US
MORE STORIES
What is a biomarker? >>
What are the symptoms of stomach cancer? >>
Daughter draws strength from late father in brain cancer battle >>
Dana-Farber Care Card
Dana-Farber Care Card
The Dana-Farber Care Card is a reloadable spending card for patients, family members, friends, staff, and other visitors to make cashless purchases for food and services.
Buy a Care Card
SAVE THE DATE
Bruce MacDonald, LICSW
Young Adult Support Group
Wednesday, November 7, 2018
5:30 – 7:00 p.m.
450 Brookline Ave., Boston, MA
Patients in their 20's and 30's who are in treatment or recently out of treatment are eligible to join this support group. Call 617-632-5657 or email Bruce MacDonald, LICSW, to register.
View events calendar
Dana-Farber Marathon Challenge runner
Dana-Farber Marathon Challenge
Monday, April 15, 2019
Boston, MA
Apply now to join Dana-Farber’s team in the 2019 Boston Marathon®, and run toward the ultimate finish line: a world without cancer.
Apply today
HOW TO HELP
Boston Red Sox World Series Championship ornament
Celebrate the Red Sox win with a limited edition ornament
Surprise your loved ones with a limited edition Red Sox World Champions holiday ornament and other Red Sox-themed items this holiday season.
Place your order today
Gene Display tiles
Make your mark on cancer
Support cancer research through the Gene Display. Deadline for February installation is December 31.
Name a gene
SUBSCRIBE >>
US News and World Report Best Hospital badges
Feedback - Thoughts
about our newsletter?
Email us
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼